Carole J. Spangler
Corporate Officer/Principal bei Clario Medical Imaging, Inc.
Profil
Carole Spangler is Head of Sales for Clario Medical Imaging, Inc. Previously, she was Director of Business Development for Dendreon Corp.
She is an Adjunct Professor at the School of Business and Economics at Seattle Pacific University.
Dr. Spangler received an MBA from the University of Washington and a PhD from the Johns Hopkins University.
Aktive Positionen von Carole J. Spangler
| Unternehmen | Position | Beginn |
|---|---|---|
Clario Medical Imaging, Inc.
 Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Carole J. Spangler
| Unternehmen | Position | Ende |
|---|---|---|
| DENDREON CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Carole J. Spangler
| The Johns Hopkins University | Doctorate Degree |
| University of Washington | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Clario Medical Imaging, Inc.
Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |